Correvio Pharma (CORV) Gross Profit Margin starting from the fourth quarter 2019 to fourth quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Correvio Pharma Corp   (CORV)


Correvio Pharma 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORV Gross Profit Margin (Dec 31 2019)
Q4 		0
Q3 		0
Q2 		0
Q1 		(Dec 31 2018)
Q4
Y / Y Revenue Change 13.81 %
Seq. Revenue Change -
Revenue In Millions $32.63
Gross Profit Margin 69.89 %
Gross Profit Margin Total Ranking # 944
Gross Profit In Millions $22.81
Y / Y Gross Profit Change 11.91 %
Seq. Gross Profit Change -


Commenting fourth quarter 2019 Gross Profit Margin



Observing fourth quarter 2019 results within Major Pharmaceutical Preparations industry 93 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 944.
Learn about Gross Margin
CORV's Gross Profit Margin fourth quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 94
Healthcare Sector # 197
Overall # 919

Gross Profit Margin Statistics
High Average Low
71.78 % 70.91 % 69.89 %
(Dec 31 2017)   (Dec 31 2019)


CORV Gross Income Trends • More of CORV's Profitabilty Ratios • CORV Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
CORV's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CORV's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CORV's Competitors
Gross Profit Margin Profit Margin for Correvio Pharma 's Suppliers
Gross Profit Margin Profit Margin for CORV's Customers

You may also want to know
CORV's Annual Growth Rates CORV's Profitability Ratios CORV's Asset Turnover Ratio CORV's Dividend Growth
CORV's Roe CORV's Valuation Ratios CORV's Financial Strength Ratios CORV's Gross Profit Growth
CORV's Roa CORV's Inventory Turnover Ratio CORV's Growth Rates CORV's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2019, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2019 MRQ Gross ProfitDec 31 2019 MRQ Revenue
Intellipharmaceutics International Inc   100.00 %$ 0.233  Millions$ 0.233  Millions
Ionis Pharmaceuticals Inc   99.80 %$ 492.668  Millions$ 493.680  Millions
Akcea Therapeutics Inc   99.48 %$ 276.046  Millions$ 277.480  Millions
Agios Pharmaceuticals Inc   99.19 %$ 35.153  Millions$ 35.440  Millions
Omeros Corporation  98.80 %$ 33.016  Millions$ 33.417  Millions
Emmaus Life Sciences Inc   98.65 %$ 15.469  Millions$ 15.681  Millions
Corcept Therapeutics Inc  98.37 %$ 86.459  Millions$ 87.895  Millions
Hutchmed china Limited  97.78 %$ 52.161  Millions$ 53.344  Millions
Global Blood Therapeutics Inc.  97.72 %$ 2.060  Millions$ 2.108  Millions
Adamas Pharmaceuticals Inc  97.30 %$ 15.906  Millions$ 16.348  Millions
Siga Technologies Inc  96.95 %$ 4.134  Millions$ 4.264  Millions
Acadia Pharmaceuticals Inc   96.93 %$ 95.306  Millions$ 98.326  Millions
Intercept Pharmaceuticals inc   96.54 %$ 69.026  Millions$ 71.500  Millions
Edesa Biotech Inc   96.50 %$ 0.104  Millions$ 0.108  Millions
Travere Therapeutics Inc   96.31 %$ 44.963  Millions$ 46.688  Millions
Bellicum Pharmaceuticals Inc   96.05 %$ 4.930  Millions$ 5.133  Millions
Supernus Pharmaceuticals inc   95.91 %$ 96.333  Millions$ 100.446  Millions
Assertio Holdings inc   95.67 %$ 56.662  Millions$ 59.225  Millions
Kadmon holdings inc   95.27 %$ 4.194  Millions$ 4.402  Millions
Pfenex Inc   95.16 %$ 20.844  Millions$ 21.905  Millions
Regeneron Pharmaceuticals Inc   95.00 %$ 2,061.000  Millions$ 2,169.500  Millions
Karyopharm Therapeutics Inc   94.40 %$ 17.083  Millions$ 18.096  Millions
Gw Pharmaceuticals Plc  93.31 %$ 101.778  Millions$ 109.076  Millions
Jazz Pharmaceuticals Plc  93.03 %$ 541.178  Millions$ 581.740  Millions
Decoy Therapeutics Inc   91.96 %$ 0.955  Millions$ 1.039  Millions
Alexion Pharmaceuticals Inc   91.74 %$ 1,270.000  Millions$ 1,384.300  Millions
Health right Discoveries Inc   91.55 %$ 0.621  Millions$ 0.678  Millions
Ironwood Pharmaceuticals inc   91.28 %$ 115.288  Millions$ 126.301  Millions
Lexicon Pharmaceuticals Inc   91.13 %$ 7.953  Millions$ 8.727  Millions
Progenics Pharmaceuticals Inc  91.02 %$ 13.768  Millions$ 15.126  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.